ConductScience.org, home

Paper356311

Tranexamic acid in the preoperative management of ruptured intracranial aneurysms.

Fodstad H and 3 others. Surg Neurol, 1978. Cited by 71 papers, by iCite.

Cite this record

ConductScience Library. Tranexamic acid in the preoperative management of ruptured intracranial aneurysms. Papers, record 356311. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/356311

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Tranexamic acid in the preoperative management of ruptured intracranial aneurysms.
PubMed
Journal
Surg Neurol
PubMed
Year
1978
PubMed
Publication types
Clinical Trial, Journal Article, Randomized Controlled Trial
PubMed
Citations, by iCite
71
iCite
Relative citation ratio, by iCite
4.28
iCite
Revised in PubMed
2013-11-21
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Fodstad HH
2Liliequist BB
3Schannong MM
4Thulin CAC A

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Cyclohexanecarboxylic AcidsMajor topic
Intracranial AneurysmMajor topic
Tranexamic AcidMajor topic
Adult
Aged
Antifibrinolytic Agents
Clinical Trials as Topic
Constriction, Pathologic
Female
Humans
Hydrocephalus
Male
Middle Aged
Postoperative Complications
Recurrence
Rupture, Spontaneous
Subarachnoid Hemorrhage

Source PubMed

Download CSV of topics

Cited by26

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 71 citations.

PMIDTitleJournalYearIn PapersSource
36350005Antifibrinolytic therapy for aneurysmal subarachnoid haemorrhage.Cochrane Database Syst Rev2022https://conductscience.org/library/papers/36350005PubMed
35140671Safety and Efficacy of Tranexamic Acid in Aneurysmal Subarachnoid Hemorrhage: A Meta-Analysis of Randomized Controlled Trials.Front Neurol2021https://conductscience.org/library/papers/35140671PubMed
35083272Efficacy and Safety of Tranexamic Acid in Aneurysmal Subarachnoid Hemorrhage: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.Front Surg2021https://conductscience.org/library/papers/35083272PubMed
34315966Tranexamic acid in non-traumatic intracranial bleeding: a systematic review and meta-analysis.Sci Rep2021https://conductscience.org/library/papers/34315966PubMed
33851983Association of Intravenous Tranexamic Acid With Thromboembolic Events and Mortality: A Systematic Review, Meta-analysis, and Meta-regression.JAMA Surg2021https://conductscience.org/library/papers/33851983PubMed
33222913Subarachnoid hemorrhage rebleeding in the first 24 h is associated with external ventricular drain placement and higher grade on presentation: Cohort study.J Clin Neurosci2020https://conductscience.org/library/papers/33222913PubMed
23990381Antifibrinolytic therapy for aneurysmal subarachnoid haemorrhage.Cochrane Database Syst Rev2013https://conductscience.org/library/papers/23990381PubMed
18386187Antifibrinolytic therapy to prevent early rebleeding after subarachnoid hemorrhage.Neurocrit Care2008https://conductscience.org/library/papers/18386187PubMed
10400410Tranexamic acid: a review of its use in surgery and other indications.Drugs1999https://conductscience.org/library/papers/10400410PubMed
7435291Effect of antifibrinolytic therapy on subarachnoid fibrosis in dogs after experimental subarachnoid haemorrhage.Acta Neurochir (Wien)1980https://conductscience.org/library/papers/7435291PubMed
7435290Letter to the editors of acta neurochirurgica. Management of patients with subarachnoid haemorrhage with tranexamic acid.Acta Neurochir (Wien)1980https://conductscience.org/library/papers/7435290PubMed
7359154Monitoring fibrinolytic activity in the cerebrospinal fluid after aneurysmal subarachnoid haemorrhage: a guide to the risk of rebleeding?J Neurol Neurosurg Psychiatry1980https://conductscience.org/library/papers/7359154PubMed
7282453Determination of tranexamic acid (AMCA) and fibrin/fibrinogen degradation products in cerebrospinal fluid after aneurysmal subarachnoid haemorrhage.Acta Neurochir (Wien)1981https://conductscience.org/library/papers/7282453PubMed
7102384Double-blind trial of aspirin in patient receiving tranexamic acid for subarachnoid hemorrhage.Acta Neurochir (Wien)1982https://conductscience.org/library/papers/7102384PubMed
7048863Antifibrinolytic treatment in subarachnoid haemorrhage: present state.Acta Neurochir (Wien)1982https://conductscience.org/library/papers/7048863PubMed
7031186Comparative clinical trial of epsilon amino-caproic acid and tranexamic acid in the prevention of early recurrence of subarachnoid haemorrhage.J Neurol Neurosurg Psychiatry1981https://conductscience.org/library/papers/7031186PubMed
7000850Tranexamic acid (AMCA) in aneurysmal subarachnoid haemorrhage.J Clin Pathol Suppl (R Coll Pathol)1980https://conductscience.org/library/papers/7000850PubMed
6741629Retrospective analysis of 162 consecutive cases of ruptured intracranial aneurysms. Total mortality and early surgery.Acta Neurochir (Wien)1984https://conductscience.org/library/papers/6741629PubMed
6179402Antifibrinolytics in aneurysmal subarachnoid haemorrhage. A retrospective comparison of two different forms of antifibrinolytic therapy.Acta Neurochir (Wien)1982https://conductscience.org/library/papers/6179402PubMed
3546604Antifibrinolytic agents in subarachnoid haemorrhage.J Neurol1987https://conductscience.org/library/papers/3546604PubMed

See all 26 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/356311

GET https://conductscience.org/api/papers/v1/356311/cited_by?page=2